BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8630107)

  • 1. Cell-type specificity of anti-CD45 autoantibodies in systemic lupus erythematosus.
    Czyzyk J; Fernsten P; Shaw M; Winfield JB
    Arthritis Rheum; 1996 Apr; 39(4):592-9. PubMed ID: 8630107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate specificity of IgM autoantibodies to CD45 in systemic lupus erythematosus.
    Fernsten PD; Czyzyk JK; Mimura T; Winfield JB
    Mol Biol Rep; 1994; 20(2):85-95. PubMed ID: 7536298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the sialosyl-Tn epitope on CD45 derived from activated peripheral blood T cells.
    Fernsten P; Shaw M; Hocker S; Fulghum R; Winfield J
    Immunol Invest; 1998 Dec; 27(6):323-38. PubMed ID: 9845419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes.
    Cappione AJ; Pugh-Bernard AE; Anolik JH; Sanz I
    J Immunol; 2004 Apr; 172(7):4298-307. PubMed ID: 15034044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus.
    Mimura T; Fernsten P; Jarjour W; Winfield JB
    J Exp Med; 1990 Aug; 172(2):653-6. PubMed ID: 2142723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
    Minota S; Winfield JB
    J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
    Winfield JB; Shaw M; Minota S
    J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to CD45 in systemic lupus erythematosus.
    Mamoune A; Saraux A; Delaunay JL; Le Goff P; Youinou P; Le Corre R
    J Autoimmun; 1998 Oct; 11(5):485-8. PubMed ID: 9802933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD45 autoantibodies mediate neutralization of activated T cells from lupus patients through anergy or apoptosis.
    Mamoune A; Kerdreux S; Durand V; Saraux A; Goff PL; Youinou P; Corre RL
    Lupus; 2000; 9(8):622-31. PubMed ID: 11035438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
    Minota S; Winfield JB
    J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
    Litvin DA; Cohen PL; Winfield JB
    J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to CD45 in systemic lupus erythematosus.
    Winfield JB; Mimura T; Fernsten PD
    Int J Clin Lab Res; 1992; 21(4):292-5. PubMed ID: 1534265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
    Spronk PE; vd Gun BT; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1993 Jul; 93(1):39-44. PubMed ID: 8100746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein specificity of cold-reactive IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
    Mimura T; Fernsten P; Shaw M; Jarjour W; Winfield JB
    Arthritis Rheum; 1990 Aug; 33(8):1226-32. PubMed ID: 2202314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on antilymphocyte antibodies in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Winchester RJ; Winfield JB; Fu SM; Wernet P; Kunkel HG
    Rheumatology; 1975; 6():209-14. PubMed ID: 1081726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
    Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
    J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of anti-lymphocyte antibody in patients with active SLE. II. Effect of anti-lymphocyte antibody on autoreactive cell clones.
    Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
    Scand J Immunol; 1980; 11(5):479-88. PubMed ID: 6966821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus.
    Clough JD; Frank SA; Calabrese LH
    Arthritis Rheum; 1980 Jan; 23(1):24-9. PubMed ID: 6965452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.